AnoshieRRatnayakeMD

Physician

Dr. Ratnayake is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (Irvine)/Children's Hospital of Orange CountyResidency, Pediatrics, 2004 - 2005
University of Texas Southwestern Medical CenterResidency, Pediatrics, 2002 - 2004
Harvard School of Public HealthMPH, 2001 - 2002
Keck School of Medicine of the University of Southern CaliforniaClass of 2001
Stanford UniversityBA, 1993 - 1997

PubMed

Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy.
R Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau, Jeffrey G Leflein, Jonathan M Spergel
Allergy. 2024-12-14
2 citations
Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age.
George Du Toit, Kari R Brown, Andrea Vereda, Anne-Marie Irani, Stephen Tilles
NEJM Evidence. 2023-11-01
15 citations
Results From a First-in-Human Study of BNZ-1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (γc) Family of Cytokines.
Paul A. Frohna, Anoshie Ratnayake, Nick Doerr, Asjad Basheer, Laith Q. Al-Mawsawi
Journal of Clinical Pharmacology. 2020-02-01

Abstracts/Posters

Blockade of IL-15 Utilizing Bnz-1, a Selective _-Chain Inhibiting Peptide, Is Safe and Has Clinical Activity in Patients with T-Cell Large Granular Lymphocytic Leukemi...
Anoshie Ratnayake, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019